Questions remaining include optimal human dosing, long-term safety, effects across different populations, interactions with diet and exercise, and whether benefits extend beyond weight loss to improvements in cardiometabolic disease outcomes
Cartilage and chondrocyte research that emerged after the obesity program ended, exploring AOD-9604's effects on osteoarthritis-relevant pathways in cartilage explants and synovial tissue models
BPC-157 and TB-500 are on the World Anti-Doping Agency prohibited list
Important Considerations Regulatory status: AOD-9604 is not FDA-approved
MHRA Borderline Classification The MHRA assesses products using their ingredients, pharmacological properties, intended purpose and complete presentation
Decreased Collagen Production in Chronologically Aged Skin